Effect of Superoxide Dismutase on Bleomycin-Induced Dermal Sclerosis: Implications for the Treatment of Systemic Sclerosis
- 1 November 1999
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 113 (5) , 843-847
- https://doi.org/10.1046/j.1523-1747.1999.00758.x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999
- Monocytes of Patients with Systemic Sclerosis (Scleroderma) Spontaneously Release In Vitro Increased Amounts of Superoxide AnionJournal of Investigative Dermatology, 1999
- SUPEROXIDE RADICAL AND SUPEROXIDE DISMUTASESAnnual Review of Biochemistry, 1995
- A radical proposal for the pathogenesis of sclerodermaJournal of the American Academy of Dermatology, 1993
- ENHANCED OXIDATIVE METABOLISM OF NEUTROPHILS FROM PATIENTS WITH SYSTEMIC SCLEROSISRheumatology, 1987
- Neutrophil‐mediated Vascular InjuryActa Medica Scandinavica, 1987
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Protection of iron-catalysed free radical damage to DNA and lipids by Copper(II)-bleomycinBiochemical and Biophysical Research Communications, 1981
- The production of hydroxyl radical by bleomycin and iron (II)FEBS Letters, 1979
- Evidence for free radical involvement in the hydroxylation of proline: Inhibition by nitro blue tetrazoliumFEBS Letters, 1972